Diabetic ketoacidosis with sodium-glucose cotransporter type 2 inhibitors: a case series
- PMID: 31420875
- DOI: 10.5694/mja2.50302
Diabetic ketoacidosis with sodium-glucose cotransporter type 2 inhibitors: a case series
Keywords: Adverse drug reactions; Diabetes mellitus, type 2; Drug-related side effects and adverse reactions.
References
-
- eTG Complete. Choice of antihyperglycaemic treatment for adults with type 2 diabetes [website]. Melbourne: Therapeutic Guidelines, 2019.
-
- Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care 2015; 38: 1687-1693.
-
- Sodium glucose co-transporter 2 inhibitor: safety advisory - diabetic ketoacidosis and surgical procedures. Therapeutic Goods Administration, 2018. https://www.tga.gov.au/alert/sodium-glucose-co-transporter-2-inhibitors; (viewed July 2019).
-
- Australian Diabetes Society. Severe euglycaemic ketoacidosis with SGLT2 inhibitor use in the perioperative period. ADS, 2018. https://diabetessociety.com.au/documents/2018_ALERT-ADS_SGLT2i_Periopera... (viewed July 2019).
-
- eTG Complete. Sick day management for adults with diabetes [website]. Melbourne: Therapeutic Guidelines, 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
